Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126369681 | 12636968 | 1 | I | 20160803 | 20160809 | 20160809 | EXP | GB-GLENMARK GENERICS (EUROPE) LTD.-2016GMK023863 | GLENMARK | 0.00 | Y | 0.00000 | 20160809 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126369681 | 12636968 | 1 | PS | VORICONAZOLE. | VORICONAZOLE | 1 | Unknown | UNK | U | 203503 | |||||||||
| 126369681 | 12636968 | 2 | I | DABIGATRAN | DABIGATRAN | 1 | Oral | 150 MG, UNK | N | 0 | 150 | MG | |||||||
| 126369681 | 12636968 | 3 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | Unknown | UNK | 0 | ||||||||||
| 126369681 | 12636968 | 4 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126369681 | 12636968 | 5 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | UNK | 0 | ||||||||||
| 126369681 | 12636968 | 6 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126369681 | 12636968 | 7 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126369681 | 12636968 | 8 | C | TERBUTALINE | TERBUTALINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126369681 | 12636968 | 9 | C | WARFARIN | WARFARIN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126369681 | 12636968 | 1 | Bronchopulmonary aspergillosis |
| 126369681 | 12636968 | 2 | Atrial fibrillation |
| 126369681 | 12636968 | 3 | Product used for unknown indication |
| 126369681 | 12636968 | 4 | Product used for unknown indication |
| 126369681 | 12636968 | 5 | Product used for unknown indication |
| 126369681 | 12636968 | 6 | Product used for unknown indication |
| 126369681 | 12636968 | 7 | Product used for unknown indication |
| 126369681 | 12636968 | 8 | Product used for unknown indication |
| 126369681 | 12636968 | 9 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126369681 | 12636968 | DS |
| 126369681 | 12636968 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126369681 | 12636968 | Blood blister | |
| 126369681 | 12636968 | Coagulation time shortened | |
| 126369681 | 12636968 | Coagulopathy | |
| 126369681 | 12636968 | Contusion | |
| 126369681 | 12636968 | Drug interaction | |
| 126369681 | 12636968 | Haemorrhage subcutaneous | |
| 126369681 | 12636968 | Pain | |
| 126369681 | 12636968 | Skin disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126369681 | 12636968 | 2 | 20160701 | 20160722 | 0 | |
| 126369681 | 12636968 | 9 | 201606 | 0 |